📰 Cassava Sciences News
Page 19 - Cassava Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cassava Sciences. Real-time updates on events, politics, business and more.
July 5, 2023
Cassava Sciences, Inc. announced top-line clinical results from its Cognition Maintenance Study . The CMS is a small proof-of-concept study designed to demonstrate the effects of drug versus placebo...
July 5, 2023
-- AXT said it has addressed the potential impact of the announcement of Chinas new export control regulations on gallium- and germanium-related materials, which take effect on Aug. 1. In Q1,...
July 5, 2023
The company announced phase 3 trial results for its lead Alzheimer's therapy.
July 5, 2023
The company announced phase 3 trial results for its lead Alzheimer's therapy.
June 27, 2023
Byrne Asset Management LLC cut its position in Cassava Sciences, Inc. (NASDAQ:SAVA – Get Rating) by 27.8% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,945 shares of the company’s stock after selling 749 shares during the quarter. Byrne Asset Management […]
June 27, 2023
Overactive mTOR Plays a Key Role in Aging and Alzheimer’s Disease.Simufilam Suppresses Overactive mTOR, Suggesting a Beneficial Drug Effect.Research is Published in Frontiers in Aging, a Peer-reviewed Journal. AUSTIN, Texas, June 27, 2023 (GLOBE ...
June 25, 2023
NEW ORLEANS, June 24, 2023 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick...
June 25, 2023
NEW ORLEANS, June 24, 2023 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC
June 23, 2023
Shares of Cassava Sciences, Inc. (NASDAQ:SAVA – Get Rating) rose 4.7% on Wednesday . The company traded as high as $25.92 and last traded at $25.91. Approximately 343,126 shares were traded during mid-day trading, a decline of 65% from the average daily volume of 972,789 shares. The stock had previously closed at $24.74. Wall Street […]
June 12, 2023
Publication Reviews Certain Receptor-Protein Interactions. Provides Overview of Basic Science Supporting Simufilam. Published in Drug Development Research, a Peer-Reviewed Journal. AUSTIN, Texas,... | June 12, 2023